Search
logo
Search
The article is in preview mode

IBS is the most common medical condition for which L4 is prescribed

Homepage Articles IBS is the most common medical condition for which L4 is prescribed

IBS is the most common medical condition for which L4 is prescribed

Diarrhoea, constipation, abdominal pain often prevent you from going to work. One of these can be IBS. A constantly running lifestyle, a poorly balanced diet, lack of physical activity, or chronic stress can affect your health, especially your bowel function. It is important to recognize and understand the cause of the problem. What is it and how to deal with it?

Table of Contents

1. What is hypersensitive bowel syndrome?

Inadomi, M.B. Bjorkman 2003). Previously, IBS was not recognized as a separate disease on any given day. (1) The Rome Statute for the Diagnostics of Inflammatory Bowel Diseases (CRB) states that it is most often associated with gastrointestinal disorders (see Figure 1) because it is not normally diagnosed by a physician, (2) because it has been studied for at least 2 weeks, (3) because it does not involve any changes in the gastroenterological disorder. (2) Because it is more commonly associated with symptoms of irritable bowel syndrome, it must be studied by physicians.

2. Translate this page to Switch Polish: Switch

In addition to pain, there is often an excess of gases, a feeling of vomiting in the stomach, diarrhea and/or constipation. However, the body's response is an individual matter. Illnesses should not be underestimated, as they can lead to serious disorders in the future. IBS also significantly impairs the mental state of patients. It can cause mood disorder and even depression.

3. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union

Nevertheless, there are several potential reasons for its occurrence: disorders of the esophageal axis of the brain, or networks of nerve cells connecting the digestive system to the central nervous system; dysbiosis, or a disorder of the microbiological balance in the gut; there is a change in the composition of the bacteria a decrease in the number of bacteria of the genus Lactobacillus and Bifidobacterium, and an increase in the numbers of Escherich coli and Pseudomonas spp.; there is also a shift in the proportion of bacteria from Bacteroides to Firmicus; ¢ gastrointestinal infections from one organism to another, which can lead to stressful or potentially unpleasant effects.

4. The following is the list of food additives used in the preparation of food preparations:

FODMAP should be used under the dietary supervision of people with fructose, lactose, fructane, galactooligosaccharides, and polyhydroxyl alcohols (sorbitol, mannitol, xylitol). The first phase of the diet usually lasts 68 weeks and involves avoiding FODAP-rich foods until the process of all foods and dietary diets. FODAMAP diets should be administered under dietary control, as improperly digested foods may lead to malnutrition.
Source

Adrych K., Zespół jelita drażliwego w świetle najnowszych wytycznych, „Forum Medycyny Rodzinnej” 2018, 12, 224–233.
Grad S., Dumitrascu D.L., Irritable Bowel Syndrome Subtypes: New Names for Old Medical Conditions, „Digestive Diseases” 2020, 38, 122–127.
Halmos E. et al., A diet low in FODMAPs reduces symptoms of irritable bowel syndrome, „Gastroenterology” 2014, 146, 67–75.
Holtmann G.J., Ford A.C., Talley N.J., Pathophysiology of irritable bowel syndrome, „The Lancet Gastroenterology and Hepatology” 2016, 1, 133–46.
Inadomi J.M., Fennerty M.B., Bjorkman D., Systematic review: the economic impact of irritable bowel syndrome, „Alimentary Pharmacology & Therapeutics” 2003, 18, 671–682.
Schnabel L., Buscail C., Sabate J., Association between ultra – processed food consumption and functional gastrointestinal disorders: results from the French NutriNet - Santé Cohort, „The American Journal of Gastroenterology” 2018, 113, 1217–1228.
Simŕen M. et al., Intestinal microbiota in functional bowel disorders: a Rome foundation report, „Gut” 2013, 62, 159–176.
Williams C.E., Williams E.A., Corfe B.M., Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: what do we know and what do we need to know?, „European Journal of Clinical Nutrition” 2018.
Żelowski A. et al., Zespół jelita nadwrażliwego – podstawowe zasady rozpoznawania i leczenia, „Pediatria i Medycyna Rodzinna” 2013, 9, 250–255.